scholarly article | Q13442814 |
P50 | author | Ralf-Harto Hübner | Q113141766 |
P2093 | author name string | Christian Thomsen | |
Norbert Suttorp | |||
Alexander Poellinger | |||
Dirk Schürmann | |||
Stefan Hippenstiel | |||
Felix Doellinger | |||
Vera Schreiter | |||
Dorothea Theilig | |||
Dominik Herzog | |||
Bettina Temmesfeld-Wollbrueck | |||
Nils Schreiter | |||
P2860 | cites work | A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema | Q28205534 |
Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study | Q28390489 | ||
Characterisation of COPD heterogeneity in the ECLIPSE cohort | Q34149510 | ||
Perfusion scintigraphy and patient selection for lung volume reduction surgery | Q34269056 | ||
Collateral ventilation. | Q34619486 | ||
Lobar analysis of collapsibility indices to assess functional lung volumes in COPD patients. | Q34700847 | ||
Effect of endobronchial valve therapy on pulmonary perfusion and ventilation distribution | Q35231269 | ||
Modifying Post-Operative Medical Care after EBV Implant May Reduce Pneumothorax Incidence | Q35641655 | ||
Bronchoscopic lung volume reduction by endobronchial valve in advanced emphysema: the first Asian report | Q35914790 | ||
Patterns of Emphysema Heterogeneity | Q36588287 | ||
Current status of bronchoscopic lung volume reduction with endobronchial valves | Q38134627 | ||
Pulmonary vascular changes in asthma and COPD. | Q38260306 | ||
Segmental approach to lung volume reduction therapy for emphysema patients | Q38286977 | ||
Biomarkers, the control panel and personalized COPD medicine. | Q38546748 | ||
An update on the efficacy of endobronchial valve therapy in the management of hyperinflation in patients with chronic obstructive pulmonary disease | Q38570787 | ||
Time for the Global Rollout of Endoscopic Lung Volume Reduction | Q38590896 | ||
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. | Q40536343 | ||
Lung Volume Reduction in Pulmonary Emphysema from the Radiologist's Perspective | Q41170996 | ||
Ventilation/perfusion SPECT/CT in patients with pulmonary emphysema. Evaluation of software-based analysing | Q41434448 | ||
Atelectasis and survival after bronchoscopic lung volume reduction for COPD. | Q43577599 | ||
Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema. | Q45883894 | ||
Diagnostic performance comparison of the Chartis System and high-resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction. | Q48083591 | ||
Multicentre European study for the treatment of advanced emphysema with bronchial valves | Q48434591 | ||
Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema | Q48461165 | ||
Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort | Q48491568 | ||
Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. | Q50541891 | ||
Comparing Clinical Outcomes in Upper versus Lower Lobe Endobronchial Valve Treatment in Severe Emphysema. | Q51597894 | ||
Ventilation/perfusion SPECT or SPECT/CT for lung function imaging in patients with pulmonary emphysema? | Q51634395 | ||
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. | Q51717981 | ||
Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. | Q52841321 | ||
Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. | Q52845001 | ||
A Randomized Study of Endobronchial Valves for Advanced Emphysema | Q52847063 | ||
Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment. | Q53163143 | ||
Volumetric and scintigraphic changes following endoscopic lung volume reduction. | Q53400628 | ||
3D-CT Lung Volumetry Using Multidetector Row Computed Tomography | Q57744861 | ||
Computed Tomography Predictors of Response to Endobronchial Valve Lung Reduction Treatment. Comparison with Chartis | Q57940939 | ||
Apical Perfusion Fraction as a Predictor of Short-term Functional Outcome Following Bilateral Lung Volume Reduction Surgery | Q60153719 | ||
Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients | Q80087457 | ||
Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD | Q81638179 | ||
Emphysema lung lobe volume reduction: effects on the ipsilateral and contralateral lobes | Q83785060 | ||
Effect of unilateral endobronchial valve insertion on pulmonary ventilation and perfusion: a pilot study | Q84574068 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pulmonary emphysema | Q188605 |
P304 | page(s) | 1245-1259 | |
P577 | publication date | 2016-06-09 | |
P1433 | published in | International Journal of Chronic Obstructive Pulmonary Disease | Q6051335 |
P1476 | title | Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy | |
P478 | volume | 11 |
Q93077247 | A New Oxygen Uptake Measurement Supporting Target Selection for Endobronchial Valve Treatment |
Q33766537 | Comparison of distinctive models for calculating an interlobar emphysema heterogeneity index in patients prior to endoscopic lung volume reduction |
Q37717803 | Endobronchial Valves for Endoscopic Lung Volume Reduction: Best Practice Recommendations from Expert Panel on Endoscopic Lung Volume Reduction |
Q41334928 | Reduced ventilation-perfusion (V/Q) mismatch following endobronchial valve insertion demonstrated by Gallium-68 V/Q photon emission tomography/computed tomography |
Q58804541 | Valve therapy in patients with emphysematous type of chronic obstructive pulmonary disease (COPD): from randomized trials to patient selection in clinical practice |
Search more.